DrDoctor

About DrDoctor

DrDoctor operates as a health-tech platform focused on bolstering productivity and communication within the United Kingdom's National Health Service (NHS). The company was established in 2012 by Tom Whicher, Perran Pengelly, and Rinesh Amin. The founders, all former management consultants, identified the opportunity while working on healthcare projects and observing firsthand the inefficiencies in hospital outpatient departments, such as issues with appointment scheduling and patient communication.

CEO Tom Whicher, a biomedical engineer by background, previously worked at a management consultancy firm where he was assigned to healthcare projects. This experience, combined with his earlier background in coding and naval architecture, shaped his approach to solving systemic problems within the NHS. Co-founders Rinesh Amin and Perran Pengelly also came from the same consultancy, with Pengelly focusing more on the IT side. Their collective frustration with the patient experience and administrative burdens led them to create DrDoctor.

The company's primary business involves providing a patient engagement platform to NHS Trusts and Health Boards. Its revenue is generated by being commissioned by these NHS organizations. DrDoctor's platform is designed to digitize and automate patient communications and administrative workflows. The service allows patients to manage their appointments online, including booking, canceling, and rescheduling. It delivers digital letters, appointment reminders via text and email, and facilitates video consultations. For the NHS Trusts, this translates into reduced administrative tasks, lower rates of missed appointments ('Did Not Attends' or DNAs) by up to 30%, and decreased paper and postage costs by up to 70%.

DrDoctor's platform, referred to as HybridOS, is a key component of its offering, designed to support a hybrid model of healthcare that blends digital and in-person services. The platform integrates with the NHS App and offers features like patient-led booking, automated slot refilling for canceled appointments, and the ability to send patients online forms. It also incorporates AI-powered tools to predict patient attendance and optimize clinic capacity. Serving over 70 NHS organizations and managing over 140 million appointments for more than 35 million patients annually, the company has achieved significant scale. A major milestone was securing £10 million in Series B funding in 2024 to accelerate product development and expand its reach.